ANDROGENETIC ALOPECIA

This study tests whether an injection called XVIE, made from processed human amniotic fluid, is safe and might help regrow hair in adults with common pattern baldness. Thirty participants will receive either XVIE or a placebo injected into the scalp, with two treatments 90 days a…

This trial investigates whether combining microneedling with a standard 5% minoxidil solution can improve hair regrowth in men with androgenetic alopecia (male pattern baldness). It will enroll 190 men aged 18-55 with specific hair loss grades, who will receive different micronee…

This trial compares three types of platelet-rich plasma (PRP) injections for androgenetic alopecia, the most common form of hair loss. Participants receive either standard PRP, PRP enhanced with red light, or PRP enhanced with blue light, and are blinded to which type they get. T…

This study tests whether a daily oral minoxidil pill (N1087) can help regrow hair in men with male pattern baldness. About 372 men aged 18 to 60 with moderate hair loss will take either the drug or a placebo for 24 weeks, with the dose slowly increased. The main goal is to see if…

This study tests whether a treatment called DA-001 can safely reduce hair shedding and promote regrowth in people with certain types of hair loss, including telogen effluvium and female or male pattern baldness. About 1,120 adults will apply the treatment as directed and be monit…

This study tests whether a single injection of nanofat (processed fat from your own body) can treat pattern hair loss better than standard options. Sixty adults with androgenetic alopecia will receive either one nanofat injection, three monthly PRP injections, or daily topical mi…

This early-stage study tests two forms of a hair loss drug (AD-303A topical and AD-3031 oral) in 30 men aged 19-55 with male pattern baldness. The goal is to see how the drug moves through the body, how well it works, and if it is safe. The study will help decide the right dose f…

This study tests whether adding a stem-cell-derived exosome solution to fractional laser therapy helps regrow hair better than laser alone. Thirty men with male pattern baldness will receive three laser sessions and be followed for six months. Researchers will measure changes in …

This study aims to train and test artificial intelligence (AI) models to diagnose male and female pattern hair loss (androgenetic alopecia) and assess its severity. Researchers will use images from a handheld dermoscope along with age and sex data from 400 participants. The goal …

This study investigates whether the bacteria living in the gut and on the scalp differ between men with androgenetic alopecia (common hair loss) and those without. Researchers will also look at how these bacterial communities change after treatment with oral minoxidil, a standard…